Skip to content

Trial Summary

Prospective, multicentre trial evaluating O-(2-[18F]-fluoroethyl)-L-tyrosine Positron Emission Tomography in Glioblastoma (FET-PET in Glioblastoma)

Acronym:

FIG

ACTRN/NCT /ethics:

ACTRN12619001735145

Scientific title:

Prospective, multicentre trial evaluating O-(2-[18F]-fluoroethyl)-L-tyrosine Positron Emission Tomography in Glioblastoma (FET-PET in Glioblastoma)

Trial & Patient Characteristics

Cancer TypeBrain
Trial TypeEarly detection, diagnosis, prognosis
PhaseAll phases
Age Range18+ years
SexBoth
Tumour StreamGlioma
Cancer Stage-
Anticipated Start Date2020-02-03
Anticipated End Date-

Participating Hospitals

HospitalRoyal Adelaide Hospital
Clinical Trial CoordinatorAnne Milton
Emailanne.milton@sa.gov.au
Phone08 7074 2342
Principal InvestigatorPeter Gorayski
Recruitment StatusNot Yet Recruiting